Microplate Readers Market Size, Share, Growth, and Industry Analysis, By Type (Optical Grating Microplate Reader,Optical Filter Microplate Reader), By Application (Nonclinical Field,Clinical Field), Regional Insights and Forecast to 2035
Microplate Readers Market Overview
The global Microplate Readers Market size is projected to grow from USD 153.75 million in 2026 to USD 164.16 million in 2027, reaching USD 277.17 million by 2035, expanding at a CAGR of 6.77% during the forecast period.
The global Microplate Readers Market has witnessed significant expansion driven by growing applications in clinical diagnostics, pharmaceutical research, and biotechnology. In 2024, over 85% of research laboratories utilized microplate readers for biochemical and cell-based assays, indicating the deep integration of these instruments in scientific workflows. Microplate readers, which can simultaneously analyze 96-, 384-, and 1536-well microplates, have become indispensable in high-throughput screening, ELISA, and fluorescence-based assays. Approximately 72% of pharmaceutical firms use these systems for compound screening and drug discovery processes.
The adoption of multi-mode microplate readers has increased by 38% in the past three years due to their capability to integrate absorbance, fluorescence, and luminescence detection modes in one platform. The industry has also observed a steady transition toward automated and digital systems, with over 60% of new installations featuring AI-assisted data analytics software and cloud integration capabilities. Continuous innovation in optical detection systems and miniaturization of assay formats have enhanced data precision by 27% and reduced reagent consumption by 30%, making the technology more sustainable and cost-efficient.
By 2025, the total installed base of microplate readers across global life science laboratories is estimated to exceed 250,000 active units, reflecting a strong growth trajectory across academic, pharmaceutical, and diagnostic sectors. The Microplate Readers Market Analysis highlights increasing investments in R&D automation, with biotechnology companies accounting for 45% of new purchases. As assay reproducibility and data accuracy remain crucial for scientific validation, microplate readers continue to be a backbone of experimental biology, with product innovation centered on high sensitivity, lower background noise, and improved data management interfaces.
The Microplate Readers Market in the USA represents one of the most technologically advanced and mature segments globally, accounting for approximately 32% of global installations in 2024. The country’s strong biopharmaceutical base, which includes more than 1,800 active biotechnology firms and 650 clinical research institutions, drives consistent demand for high-precision analytical devices. Over 70% of clinical laboratories in the United States employ microplate readers for enzyme-linked immunosorbent assays (ELISA) and cell viability tests.
Academic research centers and government-funded laboratories contribute nearly 22% of total market utilization, emphasizing the widespread adoption of plate readers for research in genomics, proteomics, and immunology. The increasing prevalence of chronic diseases—affecting over 60 million Americans—has fueled diagnostic testing using absorbance and fluorescence-based detection technologies. Automated multi-mode readers now dominate 65% of new installations due to their integration with laboratory information management systems (LIMS).
Furthermore, advancements in microplate technology have improved assay throughput by 35%, aligning with the country’s demand for faster drug discovery timelines. The USA market continues to experience strong procurement in personalized medicine development and vaccine research. According to Microplate Readers Market Research Report data, domestic production capabilities and import partnerships from Europe and Asia further strengthen the United States’ leadership position in this segment.
Key Findings
- Key Market Driver: Technological advancements, including automation and AI integration, account for 46% of total market growth. The adoption of high-throughput and multi-mode systems rose 38%, while increased R&D investment contributed 28% to expanding laboratory adoption across pharmaceutical and biotechnology sectors.
- Major Market Restraint: High equipment costs and maintenance challenges restrict 33% of potential users, particularly among small laboratories. Refurbished devices account for 28% of total installations, leading to reduced demand for new systems and limiting overall innovation adoption by 22%.
- Emerging Trends: Automation, digital integration, and AI-based data analysis define 41% of emerging innovations. Miniaturization and smart interface technologies have expanded usage by 37%, while eco-friendly and low-energy models now represent 25% of newly produced microplate reader units globally.
- Regional Leadership: North America leads with 34% market share, followed by Europe at 29% and Asia-Pacific at 27%. The Middle East & Africa contribute 10%, driven by rising healthcare investments and modernization of diagnostic laboratories across emerging nations.
- Competitive Landscape: The top five manufacturers—BioTek, BMG Labtech, Tecan, PerkinElmer, and Molecular Devices—collectively hold 52% market control. BioTek leads with 12%, followed by BMG Labtech at 10%, while regional players account for 26% of total production output.
- Market Segmentation: Optical grating readers comprise 53% of market share, favored in research laboratories, while optical filter readers hold 47%, dominating clinical diagnostics. Nonclinical applications account for 56%, and clinical segments represent 44% of global microplate reader usage.
- Recent Development: Between 2022 and 2025, automated multi-mode systems saw a 39% increase in installation rates. AI-assisted data interpretation tools improved assay accuracy by 27%, while portable and compact reader demand surged 31% across decentralized diagnostic facilities worldwide.
Microplate Readers Market Latest Trends
Recent Microplate Readers Market Trends emphasize automation, multiplexing, and data digitization. The integration of multi-mode detection technologies—absorbance, fluorescence, and luminescence—has enabled a 34% improvement in assay efficiency. Manufacturers are focusing on precision optics that enhance signal-to-noise ratios by 28%, leading to more accurate biochemical readings. Miniaturized assay plates capable of processing up to 1536 wells per plate are increasingly utilized, optimizing throughput and reducing sample volume consumption by 30%.
The adoption of touchscreen interfaces and AI-powered data analytics has surged by 37% across major laboratories. Cloud-based platforms that enable remote experiment monitoring now account for 22% of installations. Sustainability initiatives are also shaping product design, with 25% of new devices featuring low-energy LED sources and recyclable components. In research, fluorescence polarization and time-resolved fluorescence assays have grown by 29%, aligning with the demand for multiplexed biomarker analysis.
According to Microplate Readers Market Insights, instrument connectivity with laboratory automation systems has increased 31% year-on-year. Continuous technological advancement and user-centric design have established microplate readers as indispensable tools for molecular diagnostics, life science research, and drug discovery worldwide.
Microplate Readers Market Dynamics
DRIVER
"Rising demand for pharmaceuticals."
The global expansion of the pharmaceutical and biotechnology industries has fueled the widespread use of microplate readers. Over 62% of drug development laboratories depend on high-throughput microplate assays for screening, kinetic studies, and toxicity testing. The surge in biologics and vaccine development—particularly post-pandemic—has further increased equipment utilization rates by 35%. Manufacturers are integrating faster optical systems and reducing data acquisition times by 25%, significantly enhancing productivity in R&D environments.
RESTRAINT
"Demand for refurbished equipment."
Many small and mid-sized laboratories, particularly in emerging economies, are opting for refurbished or second-hand microplate readers, representing 28% of total equipment purchases. This trend, driven by cost constraints, limits the expansion of new product sales. Maintenance and calibration challenges with legacy systems also impact performance reliability, reducing laboratory efficiency by 17% compared to new-generation devices.
OPPORTUNITY
"Growth in personalized medicines."
Advancements in personalized and precision medicine have increased the use of microplate readers for genomic and proteomic assays. The number of personalized drug trials incorporating microplate-based analysis rose by 44% from 2022 to 2025. High-throughput screening of patient-derived cells has become a dominant research trend, offering a substantial opportunity for microplate reader manufacturers to design custom, application-specific instruments.
CHALLENGE
"Rising costs and expenditures."
Escalating costs of consumables, reagents, and advanced optical components have increased operational expenditure by 21%. Additionally, shortages in skilled technical personnel—particularly in APAC and MEA regions—limit adoption despite growing research activity. Manufacturers are addressing this through automation and plug-and-play system architectures that reduce setup and training time by 26%.
Microplate Readers Market Segmentation
The Microplate Readers Market is segmented by type into Optical Grating and Optical Filter systems, and by application into Nonclinical and Clinical fields, together driving diversified adoption across global pharmaceutical, research, and diagnostic laboratories.
BY TYPE
Optical Grating Microplate Reader: Optical grating microplate readers represent 53% of global installations, widely used in fluorescence, luminescence, and absorbance-based assays. Their ability to handle variable wavelengths enhances accuracy by 28%, improving performance in high-throughput drug discovery. Adoption in pharmaceutical R&D increased 31% between 2022 and 2025, with integration of multi-mode functionality in 45% of newly deployed systems.
The Optical Grating Microplate Reader Market is estimated at USD 78.5 million in 2025, holding 54.5% market share, and is forecasted to reach USD 142.7 million by 2034 at a CAGR of 6.82%.
Top 5 Major Dominant Countries in the Optical Grating Segment
- United States: Market size USD 24.3 million in 2025, 31% share, growing to USD 44.8 million by 2034 at a CAGR of 6.85%, led by pharmaceutical research adoption.
- Germany: Estimated USD 8.1 million in 2025, 10.3% share, expected to reach USD 14.8 million by 2034, registering CAGR of 6.70%, supported by strong biotechnology R&D.
- China: Valued at USD 7.5 million in 2025, 9.6% share, projected to hit USD 13.8 million by 2034 with CAGR of 6.89%, driven by diagnostic manufacturing growth.
- Japan: With USD 6.9 million in 2025, 8.8% share, it will expand to USD 12.8 million by 2034, at CAGR of 6.83%, supported by automation in analytical testing.
- United Kingdom: Estimated USD 5.6 million in 2025, 7.1% share, predicted to rise to USD 10.3 million by 2034 at CAGR of 6.79%, driven by academic laboratory integration.
Optical Filter Microplate Reader: Optical filter-based readers account for 47% of total market share and dominate routine ELISA and enzyme kinetics applications. These systems are installed in over 45% of hospital diagnostic laboratories. Known for reliability and simplicity, filter readers improved test reproducibility by 22%. Dual-mode variants saw a 25% rise in demand between 2023 and 2025, especially within clinical diagnostics.
The Optical Filter Microplate Reader Market is valued at USD 65.5 million in 2025, representing 45.5% of total market share, and expected to reach USD 116.9 million by 2034, growing at a CAGR of 6.71%.
Top 5 Major Dominant Countries in the Optical Filter Segment
- United States: Market size USD 20.8 million in 2025, 31.8% share, projected to reach USD 37.1 million by 2034, at CAGR of 6.74%, driven by clinical diagnostics expansion.
- France: Estimated USD 7.3 million in 2025, 11.1% share, expected to reach USD 13.0 million by 2034, with CAGR of 6.76%, supported by healthcare infrastructure investments.
- China: Valued at USD 6.5 million in 2025, 9.9% share, set to rise to USD 11.7 million by 2034, reflecting CAGR of 6.78%, driven by reagent-free assay development.
- India: Projected at USD 5.4 million in 2025, 8.2% share, expanding to USD 9.7 million by 2034, with CAGR of 6.80%, spurred by molecular diagnostics growth.
- Italy: Estimated USD 4.7 million in 2025, 7.2% share, expected to reach USD 8.4 million by 2034, at CAGR of 6.73%, driven by ELISA testing standardization.
BY APPLICATION
Nonclinical Field: The nonclinical segment constitutes 56% of total usage, driven by academic and industrial R&D applications. Over 70% of university laboratories utilize microplate readers for biochemical and cell-based assays. Pharmaceutical screening programs rely heavily on these systems, increasing adoption by 33% since 2021. Automation integration in nonclinical laboratories expanded by 29%, boosting throughput and data reproducibility.
The Nonclinical Field Segment holds USD 82.6 million market size in 2025, commanding 57.4% share, and is expected to reach USD 150.8 million by 2034, expanding at a CAGR of 6.79% due to high R&D utilization.
Top 5 Major Dominant Countries in the Nonclinical Field Application
- United States: Valued at USD 26.9 million in 2025, 32.6% share, projected to hit USD 49.1 million by 2034, at CAGR of 6.80%, boosted by biotechnology funding.
- Germany: Estimated USD 8.9 million in 2025, 10.8% share, expected to reach USD 16.3 million by 2034, recording CAGR of 6.76%, led by drug discovery labs.
- China: Market size USD 8.1 million in 2025, 9.8% share, will reach USD 14.8 million by 2034, at CAGR of 6.85%, fueled by genetic assay expansion.
- Japan: Valued at USD 6.7 million in 2025, 8.1% share, projected to reach USD 12.2 million by 2034, registering CAGR of 6.78%, supported by advanced automation.
- South Korea: Estimated USD 5.4 million in 2025, 6.5% share, will grow to USD 9.8 million by 2034, at CAGR of 6.82%, led by academic research initiatives.
Clinical Field: Clinical applications represent 44% of total market demand, focusing on disease diagnostics, biomarker assays, and hormone quantification. Around 68% of hospital and diagnostic centers employ microplate readers for ELISA testing. Integration with LIMS improved laboratory efficiency by 27%, while AI-enabled readers enhanced diagnostic accuracy by 23%, reflecting expanding reliance on advanced detection technologies across medical institutions.
The Clinical Field Segment is valued at USD 61.4 million in 2025, representing 42.6% share, projected to reach USD 108.8 million by 2034, expanding at a CAGR of 6.74%, supported by rising diagnostic testing demand.
Top 5 Major Dominant Countries in the Clinical Field Application
- United States: Estimated USD 22.1 million in 2025, 36% share, expected to reach USD 39.1 million by 2034, at CAGR of 6.76%, led by diagnostic laboratory upgrades.
- United Kingdom: Valued at USD 6.5 million in 2025, 10.6% share, projected to reach USD 11.5 million by 2034, at CAGR of 6.70%, driven by ELISA test adoption.
- China: Estimated USD 5.9 million in 2025, 9.6% share, will reach USD 10.4 million by 2034, at CAGR of 6.79%, supported by healthcare modernization.
- France: Valued at USD 5.3 million in 2025, 8.6% share, predicted to reach USD 9.3 million by 2034, growing at CAGR of 6.72%, due to hospital automation.
- India: Estimated USD 4.8 million in 2025, 7.8% share, expected to reach USD 8.5 million by 2034, at CAGR of 6.81%, driven by diagnostic infrastructure expansion.
Microplate Readers Market Regional Outlook
The Microplate Readers Market demonstrates balanced global distribution, with North America leading, Europe maintaining strong R&D adoption, Asia-Pacific showing rapid expansion, and the Middle East & Africa gaining traction through healthcare modernization and diagnostic infrastructure development.
NORTH AMERICA
North America accounts for 34% of the global market share, supported by advanced research infrastructure and robust biotechnology sectors. Over 68% of laboratories use multi-mode readers for fluorescence and absorbance assays. The United States leads regional demand, contributing 82% of installations, while Canada and Mexico collectively hold 18%, driven by expanding pharmaceutical manufacturing and life science research facilities.
The North America Microplate Readers Market is valued at USD 48.9 million in 2025, with 34% share, growing steadily at 6.78% CAGR.
North America - Major Dominant Countries in the Microplate Readers Market
- United States: The United States market is USD 38.6 million in 2025, holding 79% share, projected to reach USD 69.3 million by 2034, at CAGR 6.79%, driven by pharmaceutical research adoption.
- Canada: Canada’s market size is USD 4.8 million in 2025, with 9.8% share, reaching USD 8.7 million by 2034, CAGR 6.75%, led by life science R&D expansion.
- Mexico: Mexico holds USD 2.9 million in 2025, 6% share, expected to reach USD 5.2 million by 2034, CAGR 6.72%, fueled by clinical diagnostics upgrades.
- Puerto Rico: Puerto Rico is valued at USD 1.3 million in 2025, 2.6% share, projected to grow to USD 2.4 million by 2034, CAGR 6.69%, supporting biomanufacturing growth.
- Cuba: Cuba market stands at USD 1.2 million in 2025, 2.4% share, reaching USD 2.1 million by 2034, CAGR 6.68%, driven by clinical laboratory adoption.
EUROPE
Europe holds 29% of the global share, with Germany, the United Kingdom, and France being major contributors. Around 65% of European research institutions employ microplate readers for molecular and immunoassay testing. Automation adoption rose 22% from 2021 to 2024, and nearly 30% of devices comply with sustainable, low-energy designs aligning with the region’s environmental and laboratory efficiency goals.
Europe Microplate Readers Market is valued at USD 41.8 million in 2025, holding 29% share, forecast to reach USD 74.8 million by 2034, CAGR 6.74%.
Europe - Major Dominant Countries in the Microplate Readers Market
- Germany: Germany’s market is USD 9.4 million in 2025, 22.5% share, expected to grow to USD 16.8 million by 2034, CAGR 6.73%, supported by biotechnology innovation.
- United Kingdom: United Kingdom market valued at USD 7.8 million in 2025, 18.6% share, projected to reach USD 14.0 million by 2034, CAGR 6.70%, driven by clinical laboratories.
- France: France holds USD 7.3 million in 2025, 17.5% share, forecast to reach USD 13.1 million by 2034, CAGR 6.72%, supported by diagnostic testing expansion.
- Italy: Italy market stands at USD 5.9 million in 2025, 14.1% share, expected to grow to USD 10.6 million by 2034, CAGR 6.74%, driven by hospital adoption.
- Spain: Spain holds USD 4.8 million in 2025, 11.5% share, projected to reach USD 8.6 million by 2034, CAGR 6.77%, fueled by molecular research expansion.
ASIA-PACIFIC
Asia-Pacific represents 27% of the global market and shows the fastest growth in adoption. China, Japan, and India collectively account for 74% of regional demand. Laboratory installations increased from 15,000 in 2020 to 24,000 in 2024, marking a 60% rise. Expanding biotechnology investments, academic research programs, and diagnostic testing have accelerated procurement of advanced, automated microplate reader systems.
Asia-Pacific Microplate Readers Market is valued at USD 38.9 million in 2025, representing 27% share, forecast to reach USD 70.5 million by 2034, CAGR 6.80%.
Asia-Pacific - Major Dominant Countries in the Microplate Readers Market
- China: China market size is USD 12.5 million in 2025, 32% share, expected to reach USD 22.6 million by 2034, CAGR 6.83%, driven by biopharmaceutical manufacturing.
- Japan: Japan is valued at USD 8.9 million in 2025, 22.9% share, projected to grow to USD 16.1 million by 2034, CAGR 6.81%, supported by laboratory automation.
- India: India holds USD 6.7 million in 2025, 17.2% share, expected to reach USD 12.0 million by 2034, CAGR 6.79%, fueled by molecular diagnostics adoption.
- South Korea: South Korea market is USD 5.1 million in 2025, 13% share, projected to grow to USD 9.2 million by 2034, CAGR 6.76%, supported by life science research.
- Australia: Australia holds USD 4.2 million in 2025, 10.8% share, expected to reach USD 7.6 million by 2034, CAGR 6.75%, driven by clinical testing upgrades.
MIDDLE EAST & AFRICA
The Middle East & Africa contribute 10% of the total market share, driven by expanding healthcare systems and diagnostic laboratories. The UAE and Saudi Arabia represent 57% of regional demand, while South Africa holds 18%. Investments in hospital laboratories increased 26% since 2022, and growing public health initiatives are strengthening adoption of multi-mode microplate readers across new diagnostic centers.
Middle East & Africa Microplate Readers Market is valued at USD 14.4 million in 2025, holding 10% share, expected to reach USD 26.9 million by 2034, CAGR 6.73%.
Middle East and Africa - Major Dominant Countries in the Microplate Readers Market
- Saudi Arabia: Saudi Arabia market is USD 3.8 million in 2025, 26.4% share, forecast to reach USD 7.1 million by 2034, CAGR 6.77%, supported by healthcare investments.
- UAE: UAE holds USD 2.9 million in 2025, 20.1% share, projected to grow to USD 5.2 million by 2034, CAGR 6.74%, driven by medical research infrastructure.
- South Africa: South Africa is valued at USD 2.5 million in 2025, 17.3% share, expected to reach USD 4.6 million by 2034, CAGR 6.70%, driven by diagnostic automation.
- Egypt: Egypt market stands at USD 2.1 million in 2025, 14.6% share, projected to grow to USD 3.8 million by 2034, CAGR 6.71%, supported by clinical expansion.
- Qatar: Qatar is valued at USD 1.7 million in 2025, 11.8% share, expected to reach USD 3.1 million by 2034, CAGR 6.72%, driven by laboratory development initiatives.
List of Top Microplate Readers Companies
- Awareness
- Rayto
- BioTek
- Brüe ThermoFisher
- BMG Labtech
- Tecan
- Perlong
- Berthold
- Promega
- PerkinElmer
- Autobio
- Molecular Devices
- KHB
- Biochrom
- BIO-RAD
Top Two companies with the highest market share:
- BioTek Instruments (Agilent Technologies): Holds approximately 12% of global market share through its advanced multimode readers with automation compatibility.
- BMG Labtech: Commands nearly 10% share with strong performance in fluorescence and luminescence platforms.
Investment Analysis and Opportunities
Investments in the Microplate Readers Market have increased substantially due to rapid laboratory automation and the global push for efficient diagnostics. Over 48% of new capital expenditure in life sciences is directed toward high-throughput equipment, including microplate readers. Venture funding in biotech startups focusing on assay innovation grew 37% between 2022 and 2025, highlighting favorable market sentiment. Government-funded research initiatives in North America and Asia-Pacific contributed to the establishment of more than 3,200 new laboratories equipped with microplate technology.
Emerging opportunities include AI-integrated microplate readers capable of predictive analytics and assay optimization. These systems have achieved 33% higher data accuracy and are being rapidly adopted by large pharmaceutical enterprises. Additionally, regional manufacturing expansion in Asia-Pacific is expected to increase local production capacity by 40%, reducing equipment costs for research institutions.
The Microplate Readers Industry Analysis also identifies strategic mergers and partnerships as key growth catalysts, with over 15 acquisitions in the last three years among top manufacturers. The sector presents attractive opportunities for investors focusing on healthcare automation, smart laboratory ecosystems, and reagent optimization platforms.
New Product Development
Innovation in the Microplate Readers Market is centered around improving sensitivity, throughput, and data handling. Manufacturers are introducing hybrid readers combining absorbance, fluorescence, and luminescence detection modes. In 2024, over 18 new models featuring miniaturized optics and cloud integration were launched globally. Advanced detection technologies improved signal sensitivity by 26% while reducing background interference by 19%.
BioTek’s hybrid multi-mode systems achieved 30% faster read times, setting a new benchmark for high-throughput screening. BMG Labtech introduced environmentally friendly models using 15% less power consumption. Integration of IoT-based monitoring systems in next-generation devices has enabled real-time data transfer, utilized in 20% of top-tier pharmaceutical labs.
The ongoing trend toward portable and bench-top microplate readers is driven by 35% increase in point-of-care testing applications. Future innovations are expected to focus on AI-driven diagnostics and reagent-free imaging assays. Enhanced connectivity, data traceability, and ergonomic design continue to redefine user experience and analytical reliability.
Five Recent Developments
- 2023: BioTek introduced a hybrid reader integrating triple-mode detection, improving read efficiency by 25%.
- 2023: BMG Labtech launched a touchscreen-driven model with 20% higher throughput for kinetic assays.
- 2024: Molecular Devices unveiled an AI-powered reader improving fluorescence signal processing by 28%.
- 2024: PerkinElmer enhanced multi-mode reader optics, achieving 32% lower error margins in enzyme assays.
- 2025: Tecan released a smart reader compatible with automated liquid handlers, increasing workflow efficiency by 35%.
Report Coverage of Microplate Readers Market
The Microplate Readers Market Research Report offers detailed insights into product types, applications, and regional performance across the life sciences sector. Covering over 40 key manufacturers and 25 countries, the report presents a full analysis of market trends, emerging technologies, and application growth patterns. It evaluates segmentation by detection mode, end-use industry, and automation capability, providing actionable insights for manufacturers and investors.
The report includes competitive benchmarking, technology roadmaps, and supply chain evaluations highlighting over 150,000 laboratory installations globally. Emphasis is placed on innovation trends in multimode detection and AI-assisted data analytics. The Microplate Readers Market Outlook also examines regulatory frameworks and standardization efforts across diagnostic and pharmaceutical sectors.
Additionally, the report discusses evolving market dynamics shaped by automation, reagent cost optimization, and instrument digitization. Stakeholders gain insights into investment feasibility, emerging application areas, and upcoming product launches influencing market direction.
Microplate Readers Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 153.75 Million in 2026 |
|
|
Market Size Value By |
USD 277.17 Million by 2035 |
|
|
Growth Rate |
CAGR of 6.77% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Microplate Readers Market is expected to reach USD 277.17 Million by 2035.
The Microplate Readers Market is expected to exhibit a CAGR of 6.77% by 2035.
Awareness,Rayto,BioTek,Brüe ThermoFisher,BMG Labtech,Tecan,Perlong,Berthold,Promega,PerkinElmer,Autobio,Molecular Devices,KHB,Biochrom,BIO-RAD
In 2026, the Microplate Readers Market value stood at USD 153.75 Million.